MRNA

Moderna Inc

186.29

Oct 01 • 8:58 AM ET -6.28 (-3.26%)

Healthcare Biotechnology USA Large NASD

Sep 30, 8:20 AMCiti downgrades Moderna to Sell, raises price target to $80 below recent price after 222% post-INTerpath-001 rally

Peers: BNTX ALNY INCY REGN ARGX BMRN VRTX BIIB AMGN GILD

| Held by: VTI VOO VB IVV SPY VBR IBB XLV CGGR IWR

Scroll to Statements

Index	S&P 500
Market Cap	74.37B
Enterprise Value	70.52B
Income	-3.15B
Sales	2.23B
Book/sh	16.94
Cash/sh	12.87
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	4700
IPO	Dec 07, 2018

P/E	-
Forward P/E	-
PEG	-
P/S	33.38
P/B	10.99
P/C	14.48
P/FCF	-
EV/EBITDA	-
EV/Sales	31.65
Quick Ratio	2.18
Current Ratio	2.29
Debt/Eq	0.19
LT Debt/Eq	0.18
Option/Short	Yes / Yes

EPS (ttm)	-7.98
EPS next Y	-4.73
EPS next Q	-1.10
EPS this Y	-14.57%
EPS next Y	43.11%
EPS next 5Y	28.08%
EPS past 3/5Y	- -29.93%
Sales past 3/5Y	-53.32% 19.33%
EPS Y/Y TTM	-6.22%
Sales Y/Y TTM	-27.62%
EPS Q/Q	7.60%
Sales Q/Q	2.11%
Earnings	Jul 31 BMO
EPS/Sales Surpr.	3.06% 40.87%

Insider Own	8.47%
Insider Trans	-2.30%
Inst Own	79.86%
Inst Trans	2.15%
ROA	-27.43%
ROE	-39.00%
ROIC	-39.41%
Gross Margin	12.57%
Oper. Margin	-149.01%
Profit Margin	-141.43%
SMA20	12.56%
SMA50	54.06%
SMA200	175.69%
Trades

Shs Outstand	399.00M
Shs Float	365.41M
Short Float	9.00%
Short Ratio	1.92
Short Interest	32.87M
52W High	208.90 -10.82%
52W Low	22.28 736.14%
Volatility	6.57% 7.29%
ATR (14)	12.79
RSI (14)	64.12
Beta	1.09
Rel Volume	0.38
Avg Volume	17.08M
Volume	324,959

Perf Week	-4.38%
Perf Month	20.76%
Perf Quarter	133.57%
Perf Half Y	272.36%
Perf YTD	531.71%
Perf Year	574.97%
Perf 3Y	80.36%
Perf 5Y	-45.38%
Perf 10Y	-
Recom	2.89
Target Price	116.53
Prev Close	192.57
Price	186.29
Change %	-3.26%

Date	Action	Analyst	Rating Change	Price Target Change
Sep-30-26	Downgrade	Citigroup	Neutral → Sell	$80
Sep-03-26	Downgrade	Rothschild & Co Redburn	Neutral → Sell	$81
Aug-28-26	Upgrade	Argus	Hold → Buy	$180
Aug-25-26	Upgrade	Wolfe Research	Underperform → Peer Perform
Aug-19-26	Upgrade	William Blair	Mkt Perform → Outperform
Aug-19-26	Upgrade	BofA Securities	Underperform → Neutral
Jan-28-26	Resumed	Barclays	Equal Weight	$25
Jan-07-26	Resumed	UBS	Neutral	$34
Dec-12-25	Initiated	Jefferies	Hold	$30
Mar-13-25	Initiated	Citigroup	Neutral	$40
Feb-18-25	Downgrade	Barclays	Overweight → Equal Weight	$111 → $45
Jan-29-25	Downgrade	Goldman	Buy → Neutral	$99 → $51
Dec-18-24	Downgrade	Argus	Buy → Hold
Dec-10-24	Resumed	BofA Securities	Underperform	$41
Nov-19-24	Initiated	Berenberg	Hold	$42
Nov-18-24	Upgrade	HSBC Securities	Hold → Buy	$58
Nov-15-24	Initiated	Wolfe Research	Underperform	$40
Oct-17-24	Initiated	Bernstein	Mkt Perform	$55
Sep-13-24	Downgrade	Oppenheimer	Outperform → Perform
Sep-13-24	Downgrade	JP Morgan	Neutral → Underweight	$88 → $70

Show Previous Ratings

Today 08:03AM	Is A Cancer Vaccine Coming? Moderna, Merck Boosted By The Buzz (Investor's Business Daily)
03:18AM	Everpure Stock Is Septembers Surprise S&P 500 Winner, Surging More Than 40% As Retail Piles In (Stocktwits)
Sep-30-26 05:09PM	Moderna, Cerebras, Jabil, HPE, Cal-Maine, Mattel, and More Stocks That Explain Today's Market (Barrons.com) -5.35%
04:12PM	After Moderna's Dizzying Rally, It's Time To Sell, Says Analyst (Investor's Business Daily)
03:31PM	Moderna Stock Slumps as Citi Says Its Time to Sell After 500% Rally This Year (Investopedia)
11:28AM	Loading…
11:28AM	Moderna and Fair Isaac: The Best and Worst S&P 500 Stocks for the Third Quarter (Barrons.com)
10:59AM	Citi tells investors it's time to sell Moderna after 600%-plus stock gains (MarketWatch)
10:49AM	Moderna Shares Tumble After Citi Delivers Stark Sell Rating (GuruFocus.com)
09:41AM	Tech leads stocks higher after cooler-than-expected inflation read: AlphaCheck (Yahoo Finance)
09:40AM	Target upgraded, Moderna downgraded: Wall Street's top analyst calls (The Fly)
08:03AM	MRNA Stock Falls Premarket After Citi Downgrade: Analyst Says Valuation Looks Stretched Despite Cancer Vaccine Momentum (Stocktwits)
08:02AM	Premarket movers: Micron; Boeing rises, Moderna slides (Investing.com)
07:42AM	Moderna Stock Has Run Too Far, Too Fast. Why Citi Just Downgraded It to Sell. (Barrons.com)
07:00AM	Moderna Adds Chief Operating Officer Role as Company Expands into Oncology (ACCESSWIRE)
Sep-28-26 06:29AM	Intel's stock drops as AI fears mount, and other early market movers (MarketWatch)
03:59AM	Loading…
03:59AM	MRNA Stock Eyes Best Year Ever: Analyst Calls Chinas AI Drug Lead Baseless As Moderna Awaits Cancer Data (Stocktwits)
03:37AM	Stock Market Today: Dow, S&P 500 and Nasdaq set to fall after Trump rejects Iran offer; Oil climbs, Treasury yields jump; Nvidia stock rises (MarketWatch)
12:47AM	Why Did AMD, HPE, MRNA Stocks Surge To 52-Week Highs Last Week? (Stocktwits)
Sep-27-26 08:46AM	Innovation Is Driving a New Bull Market in Biotech. 16 Ways to Play It, From Our Roundtable Experts. (Barrons.com)
Sep-25-26 02:37PM	MRNA, PGEN Stocks Hit Multi-Year Highs Whats Driving The Momentum Today? (Stocktwits)
11:39AM	Innovation Is Driving a New Bull Market in Biotech. 16 Ways to Play It, From Our Roundtable Experts. (Barrons.com)
01:07AM	Moderna Stock Jumped 7% Thursday. The Real Test Comes at ESMO on October 24. (TIKR)
Sep-24-26 11:23PM	MRNA On Track To Be September's No. 2 S&P 500 Stock But These 5 Smaller Health Care Names Did Even Better (Stocktwits) +6.98%
06:41PM	From $63 To $195: Modernas Two-Month Rerating Isnt Done (Stocktwits)
Sep-23-26 11:52PM	Why Did META, MRNA, OKTA Stocks Surge To 52-Week Highs Today? (Stocktwits)
01:54PM	These 2 Stocks Are Bucking The Broader Market Selloff To Hit New Multi-Year Highs Heres Whats Driving The Enthusiasm (Stocktwits)
12:53PM	Moderna CEO's Surprising Comment Gives Clues About Where Drugmaker Is Going Next (Barrons.com)
08:28AM	6 'Moonshot' Biotech Stocks That Offer Big Risks, Bigger Rewards (Barrons.com)
01:45AM	These 'Moonshot' Biotech Stocks Could Break Out, Morgan Stanley Says. What Must Go Right. (Barrons.com)
Sep-22-26 01:39PM	Was Moderna Stock's Cancer Vaccine Run Visible In Advance? (Trefis) +5.56%
03:33AM	Loading…
03:33AM	Moderna Stock Jumped 12% Yesterday. An ESMO Presidential Slot Explains Why. (TIKR)
Sep-21-26 11:39PM	Why Did AMD, WBD, MRNA Stocks Surge To 52-Week Highs Today? (Stocktwits) +12.27%
03:43PM	Moderna will reveal the data for its mRNA cancer vaccine next month. Here's why it matters. (MarketWatch)
01:40PM	Moderna To Present Additional Data From Key Melanoma Trial At ESMO Congress Retail Says Breakout Is Getting Hard To Ignore (Stocktwits)
01:12PM	Moderna Stock Jumps. Its mRNA Cancer Vaccine Is Getting Ready for Its Next Big Test. (Barrons.com)
10:12AM	Moderna Announces Late-Breaking Data to be Presented at ESMO Congress 2026 (ACCESSWIRE)
03:00AM	Modernas Bob Langer and AI pioneer Yann LeCun join board of Cellular Intelligence, bringing AI into medicine via a Parkinsons drug (Fortune)
Sep-20-26 05:14PM	3 Bullish Setups for the Week Ahead (Zacks)
Sep-18-26 08:27AM	One stock is up 540%, and it's not alone (GuruFocus.com)
08:03AM	Dow Jones Futures: After S&P 500, Nasdaq Rebound, What's Next? Moderna, AMD, SpaceX Flash Buy Signals. (Investor's Business Daily)
Sep-17-26 03:52PM	Will 2026 Doom and Gloom Lead to Opportunity? (Zacks) +8.55%
12:32PM	Moderna: Another Day, Another Big Stock Move. Is the Cancer Vaccine Rally Back On? (Barrons.com)
03:21AM	This Tiny Biotech Is Beating MRNA, IOVA And SLS Here's How A Billionaire Fueled Its September Rally (Stocktwits)
Sep-14-26 10:00AM	AI Drug Discovery Market Projected to Reach $13.8 Billion by 2033 (PR Newswire)
Sep-13-26 04:34PM	Dow Jones Futures: Will Anthropic-Led Call For Slowdown Hit AI Stocks? Fed Meeting Aheadan, SpaceX's Musk Call For AI Slowdown (Investor's Business Daily)
Sep-11-26 04:40PM	How Cathie Wood's Fund Gave Us A Back Door To Moderna's Breakthrough (Investor's Business Daily) +5.38%
Sep-10-26 05:17AM	mRNA cancer vaccines biggest barriers to market (Pharma Voice)
Sep-08-26 04:50PM	AI, Cancer Vaccines, and Next-Gen Medicine (Zacks)
Sep-07-26 09:49PM	The Cure for Cancer is Becoming an Investable Opportunity: Analyst Sees $600 Million for Tempus AI (BeInCrypto)
Sep-04-26 06:10AM	GSK's mRNA flu vaccine data closely tracks Moderna's, Deutsche Bank says (Proactive)
Sep-03-26 01:39PM	Healthcare Stocks Pick Up Steam as Investors Play Offense and Defense (Barrons.com)
11:10AM	Why Moderna Stock's Cancer Vaccine Rally Sparked a Rare Sell Rating (Barrons.com)
09:31AM	Broadcom upgraded, Ultragenyx downgraded: Wall Street's top analyst calls (The Fly)
Sep-02-26 02:45PM	15 Stocks to Watch With Short Squeeze Potential (Schaeffer's Research)
12:02AM	Biotech Is Popping. No One Seems to Care. (The Daily Upside)
Sep-01-26 11:12AM	GSK hopes to take on Moderna as it moves mRNA flu vaccine to Phase III trial (Clinical Trials Arena) +9.93%
08:40AM	Enterprise software led August's rebound as AI fears faded, Cramer says (Quartz)
08:37AM	S&P 500 biggest August 2026 winners: Moderna, software stocks (Quartz)
07:00AM	Moderna to Present at Upcoming Conferences in September 2026 (ACCESSWIRE)
Aug-31-26 02:20PM	These ETFs capture some of the biggest market moves in August (MarketWatch)
12:50PM	Moderna Led the S&P 500 in August as Edison International Sank (Barrons.com)
12:22PM	22 best-performing stocks of August, as the software industry continues its recovery (MarketWatch)
11:59AM	Six stocks are on pace for their best month on record (MarketWatch)
Aug-28-26 01:22PM	BNTX Stock On Track For Worst Day Since March After Cancer Vaccine Trial Halt BMO Capital Terms It Clear Setback (Stocktwits)
10:46AM	BioNTech Stock Falls on Cancer Vaccine Setback (Barrons.com)
10:09AM	BioNTech drops 10% on mRNA trial failure, highlighting Moderna contrast (Investing.com)
09:38AM	Moderna upgraded, Allstate downgraded: Wall Street's top analyst calls (The Fly)
07:59AM	Moderna raises $2.6B to support cancer work; FDA clears updated COVID vaccines (BioPharma Dive)
07:00AM	Moderna Announces Pricing of Upsized $2.6 Billion Offering of Convertible Senior Notes (ACCESSWIRE)
Aug-27-26 03:56PM	Moderna Receives U.S. FDA Approval for Updated 2026-2027 COVID-19 Vaccines (ACCESSWIRE)
09:26AM	Modernas $2B Convertible-Note Deal To Focus On Oncology Growth, Debt Repayment But Retail Calls It A Bull Trap (Stocktwits)
08:30AM	Moderna is raising $2 billion in convertible debt to fund its cancer drug push (Quartz)
08:20AM	Moderna raises $2 billion in convertible notes for cancer vaccine (Quartz)
07:20AM	Moderna Announces Proposed Private Placement of $2.0 Billion of Convertible Senior Notes (ACCESSWIRE)
03:09AM	SLS, IBRX Eye Fresh Oncology Tailwind As Cathie Woods ARK Backs Personalized Cancer-Vaccine Future (Stocktwits)
Aug-26-26 02:48PM	Novavax Stock Pulls Back After Milestone Vaccine Success (Schaeffer's Research) -5.77%
01:49PM	Energy, Industrials, and Utilities Are Leading the Stock Market (Barrons.com)
11:13AM	Moderna Stock Carries A Market Value Its Revenue Does Not Support (Trefis)
08:00AM	Binance offering perpetual contracts with 20x leverage: How not to invest? (Yahoo Finance Video)
Aug-25-26 07:55PM	Review & Preview: Risky Business (Barrons.com) +14.36%
06:43PM	MRNA Stock Jumps 14% Past $150 As Wolfe Sees $9.2B Cancer-Vaccine Opportunity (Stocktwits)
05:22PM	KURA Stock Hits Fresh 52-Week High As CEO Buys More Shares Retail Wonders If Wilson Is Following Moderna CEOs Playbook (Stocktwits)
01:46PM	Moderna's Cancer Vaccine Gives Stock a New Growth Story. Will It Have a Happy Ending? (Barrons.com)
01:17PM	Moderna Stock Soars on Cancer Vaccine Breakthrough (GuruFocus.com)
11:54AM	3 Reasons AI Stocks are Primed for a Rebound (Zacks)
10:37AM	What Happens if Moderna's Cancer Vaccine Works (Barrons.com)
08:43AM	After Moderna's $44B Oncology Win, Silexion's Pancreatic Cancer Treatment is Worth Exploring (NASDAQ: SLXN) (FinanceWire)
07:12AM	Moderna Shares Rebound After Pullback Following Cancer Vaccine Rally (InvestorsHub)
Aug-24-26 03:01PM	Moderna Stock Had A Readout Waiting In Plain Sight (Trefis)
02:50PM	Analysts See Drastic Change For This Particular Part Of Healthcare (Investor's Business Daily)
02:23PM	What Is Really Moving Tempus AI Stock Right Now? (Trefis)
10:45AM	Moderna Is Betting Big on Its Cancer Vaccine. This Is What Wall Street Wants to See. (Barrons.com)
10:00AM	Nvidia earnings may come down to guidance and Jensen Huang's confidence (Yahoo Finance Video)
08:37AM	GeoVax Applauds Clinical Validation of Combination Immunotherapy Strategies (NewMediaWire)
07:42AM	Analysts praise intismerans landmark Phase III win, look to further data (Clinical Trials Arena)
Aug-23-26 11:36PM	SLS Stock Charges Ahead As AML Trial Buzz Builds: Report Claims Regal Hit 80th Event Retail Isnt Convinced (Stocktwits)
05:30AM	Hype for Moderna's Cancer Vaccine Is Running Ahead of the Math (The Wall Street Journal)
Aug-21-26 08:19PM	ARCT Surges Over 60% Toward Best Week In Year As Moderna Cancer Win Lifts Sector Retail Says Arcturus Getting Harder To Dismiss (Stocktwits) +8.86%
08:00PM	How a Big Bet on Cancer Vaccines Brought Moderna Back from the Brink (The Wall Street Journal)
06:14PM	3 American Stocks Showing the Same Setup That Sent Moderna Up 177% (BeInCrypto)

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

CEO & DirectorMr. Stephane Bancel M.B.A.

PresidentDr. Stephen Hoge M.D.

Chief Financial OfficerMr. James M. Mock

Chief Legal Officer & Corporate SecretaryMs. Shannon Thyme Klinger J.D.

Chief Technical Operations & Quality OfficerDr. Jerh Collins Ph.D.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Hoge Stephen	President	Sep 14 '26	Option Exercise	12.21	76,453	933,491	1,566,152	Sep 16 04:48 PM
Hoge Stephen	President	Sep 15 '26	Option Exercise	12.21	76,452	933,479	1,602,310	Sep 16 04:48 PM
Hoge Stephen	President	Sep 15 '26	Sale	146.07	40,281	5,883,846	1,562,029	Sep 16 04:48 PM
Hoge Stephen	President	Sep 14 '26	Sale	144.13	40,294	5,807,574	1,525,858	Sep 16 04:48 PM
Hoge Stephen	Officer	Sep 15 '26	Proposed Sale	146.07	40,281	5,883,709		Sep 15 10:46 AM
Mock James M	Chief Financial Officer	Sep 10 '26	Option Exercise	30.96	19,836	614,123	94,211	Sep 14 04:25 PM
Mock James M	Chief Financial Officer	Sep 10 '26	Sale	134.49	34,836	4,685,094	59,375	Sep 14 04:25 PM
Hoge Stephen	Officer	Sep 14 '26	Proposed Sale	144.13	40,294	5,807,746		Sep 14 02:39 PM
Mock James M	Officer	Sep 10 '26	Proposed Sale	134.49	34,836	4,685,094		Sep 10 10:14 AM
Klinger Shannon Thyme	Chief Legal Officer	Sep 01 '26	Option Exercise	30.96	3,471	107,462	77,600	Sep 03 04:56 PM
Klinger Shannon Thyme	Chief Legal Officer	Sep 01 '26	Sale	139.95	3,471	485,766	74,129	Sep 03 04:56 PM
Klinger Shannon Thyme	Officer	Sep 01 '26	Proposed Sale	139.95	3,471	485,766		Sep 01 11:22 AM
Bancel Stephane	Chief Executive Officer	Aug 05 '26	Option Exercise	19.15	499,246	9,560,561	6,687,037	Aug 07 04:11 PM
Bancel Stephane	Chief Executive Officer	Aug 06 '26	Option Exercise	19.15	252,469	4,834,781	6,440,260	Aug 07 04:11 PM
Bancel Stephane	Chief Executive Officer	Aug 05 '26	Sale	57.52	499,246	28,715,011	6,187,791	Aug 07 04:11 PM
Bancel Stephane	Officer	Aug 05 '26	Proposed Sale	58.00	499,246	28,956,268		Aug 05 01:02 PM
Hoge Stephen	President	Jul 15 '26	Option Exercise	19.15	53,336	1,021,384	1,537,184	Jul 16 04:45 PM
Hoge Stephen	President	Jul 15 '26	Sale	67.60	53,336	3,605,514	1,483,848	Jul 16 04:45 PM
Hoge Stephen	Officer	Jul 15 '26	Proposed Sale	67.60	53,336	3,605,514		Jul 15 10:22 AM
SAGAN PAUL	Former Director	Jun 18 '26	Proposed Sale	64.57	25,770	1,663,875		Jun 18 03:26 PM
Hoge Stephen	President	Jun 15 '26	Option Exercise	19.15	53,336	1,021,384	1,537,184	Jun 17 04:10 PM
Hoge Stephen	President	Jun 15 '26	Sale	51.37	53,336	2,739,870	1,483,848	Jun 17 04:10 PM
Hoge Stephen	Officer	Jun 15 '26	Proposed Sale	51.37	53,336	2,739,870		Jun 15 11:43 AM
Klinger Shannon Thyme	Chief Legal Officer	Jun 04 '26	Option Exercise	30.96	3,471	107,462	70,939	Jun 08 04:34 PM
Klinger Shannon Thyme	Chief Legal Officer	Jun 04 '26	Sale	50.00	3,471	173,550	67,468	Jun 08 04:34 PM
Klinger Shannon Thyme	Officer	Jun 04 '26	Proposed Sale	50.00	3,471	173,550		Jun 04 01:26 PM
AFEYAN NOUBAR	Director	May 21 '26	Option Exercise	19.15	9,263	177,386	13,187	May 22 07:00 PM
AFEYAN NOUBAR	Director	May 21 '26	Sale	46.84	9,263	433,879	3,924	May 22 07:00 PM
Flagship Pioneering, LLC	Affiliate	May 21 '26	Proposed Sale	46.84	9,263	433,880		May 21 03:06 PM
Hoge Stephen	President	May 15 '26	Option Exercise	19.15	53,336	1,021,384	1,531,333	May 18 04:57 PM
Hoge Stephen	President	May 15 '26	Sale	48.40	53,336	2,581,462	1,477,997	May 18 04:57 PM
Hoge Stephen	Officer	May 15 '26	Proposed Sale	48.40	53,336	2,581,462		May 15 09:47 AM
SAGAN PAUL	Former Director	May 08 '26	Proposed Sale	54.48	36,759	2,002,787		May 08 11:24 AM
Hussain Abbas	Director	May 01 '26	Sale	46.63	5,682	264,952	12,066	May 04 05:25 PM
Hussain Abbas	Director	May 01 '26	Proposed Sale	46.63	5,682	264,952		May 01 11:44 AM
Klinger Shannon Thyme	Chief Legal Officer	Mar 02 '26	Option Exercise	30.96	13,885	429,880	73,574	Mar 03 04:10 PM
Klinger Shannon Thyme	Chief Legal Officer	Mar 02 '26	Sale	52.29	13,885	726,047	59,689	Mar 03 04:10 PM
Klinger Shannon Thyme	Officer	Mar 02 '26	Proposed Sale	52.29	13,885	726,047		Mar 02 09:56 AM
Hoge Stephen	President	Feb 23 '26	Option Exercise	19.15	160,009	3,064,172	1,617,436	Feb 25 04:49 PM
Hoge Stephen	President	Feb 23 '26	Sale	48.84	160,009	7,814,840	1,457,427	Feb 25 04:49 PM
Hoge Stephen	Officer	Feb 23 '26	Proposed Sale	48.84	160,009	7,814,840		Feb 23 10:26 AM
AFEYAN NOUBAR	Director	Dec 11 '25	Option Exercise	10.90	23,853	259,998	27,777	Dec 15 09:00 AM
AFEYAN NOUBAR	Director	Dec 11 '25	Sale	29.48	23,853	703,306	3,924	Dec 15 09:00 AM
Bancel Stephane	Chief Executive Officer	Dec 11 '25	Option Exercise	10.90	688,073	7,499,996	6,181,970	Dec 15 08:59 AM
Flagship Pioneering Inc.	Affiliate	Dec 11 '25	Proposed Sale	29.49	23,853	703,306		Dec 11 04:30 PM
Hussain Abbas	Director	Dec 09 '25	Sale	27.60	504	13,910	1,515	Dec 11 04:16 PM
Hussain Abbas	Director	Dec 09 '25	Proposed Sale	27.60	504	13,910		Dec 09 10:26 AM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

MRNA

Moderna Inc

Upgrade your Finviz experience